{
    "cancelStatus": "1",
    "cancelDate": "2012-11-06",
    "cancelReason": [
        "838"
    ],
    "licid": "06016326",
    "validDate": "2011-04-10 00:00:00.000",
    "issueDate": "2006-04-10 00:00:00.000",
    "licKind": "09",
    "oldLicid": null,
    "certNo": "DHA00601632600",
    "prodNameC": "伯樂亞 細胞巨大性病毒 免疫球蛋白G",
    "prodNameE": "Platelia CMV IgG",
    "indicationsName": [],
    "does": null,
    "packageUnit": [],
    "medMCode": null,
    "maMedCode": null,
    "medDCode": null,
    "ingredientsDesc": [
        "MT PLATE  wells coated with Cytomegalovirus.\\n\\nCAL ：Diluted human serum, containing known concentrations of anti-CMV IgG\\nantibodies, in Phosphate buffer 0.01 mol\/L with BSA 1% and sodium azide 0.09% \\n\\nCONJ ：monoclonal antibodies labelled with Peroxidase, in phosphate buffer solution\\ncontaining phenol 0.05% and Bronidox 0.02%. \\n\\nCONTROL IgG ：Human serum not containing anti-CMV IgG antibodies, diluted in Phosphate buffer 0.01 mol\/L, with BSA 1% and sodium azide 0.09%.\\n\\nWASH BUF 10x ：Phosphate buffered saline, concentrated 10 times; contains Brij 0.5%.\\n\\nSAMP DIL 50x ： Proteic solution concentrated 50 times, with added phenol 0.05% and Bronidox 0.02%.\\n\\nSUBS TMB ：Tetramethylbenzidine 0.26 mg\/mL and hydrogen peroxide 0.01% stabilised in\\ncitrate buffer 0.05 mol\/L (pH 3.8).\\nH2SO4 0.3 M ：H2SO4 0.3 mol\/L.\\n\\n"
    ],
    "restraintItemsCode": [
        "R02"
    ],
    "applicantName": "美商伯瑞股份有限公司台灣分公司",
    "applicantAddr": "台北市松山區南京東路4段126號14樓",
    "medClass": "2",
    "efficacy": "對抗人類血清中細胞巨大性病毒IgG一級抗體的定性和定量的測定的免疫酵素法。 ",
    "mdFormat": "#72680  96 Tests#72691  960 Tests",
    "productAnnotation": null,
    "mdKind": [
        {
            "mdKindMCode": "C",
            "mdKindMCodeName": "C 免疫學及微生物學裝置",
            "mdKindDCode": "C.3175",
            "mdKindDCodeName": "C.3175 巨細胞病毒血清試劑",
            "checkChange": "Y"
        }
    ],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "BIO-RAD",
            "factoryAddr": "3BD RAYMOND POINCARE 92430 MARNES-LA-COQUETTE FRANCE",
            "factoryCompanyAddr": null,
            "countryCode": "FR",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "MFR0161000",
            "factoryInfo": "1",
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "MT PLATE  wells coated with Cytomegalovirus.\\n\\nCAL ：Diluted human serum, containing known concentrations of anti-CMV IgG\\nantibodies, in Phosphate buffer 0.01 mol\/L with BSA 1% and sodium azide 0.09% \\n\\nCONJ ：monoclonal antibodies labelled with Peroxidase, in phosphate buffer solution\\ncontaining phenol 0.05% and Bronidox 0.02%. \\n\\nCONTROL IgG ：Human serum not containing anti-CMV IgG antibodies, diluted in Phosphate buffer 0.01 mol\/L, with BSA 1% and sodium azide 0.09%.\\n\\nWASH BUF 10x ：Phosphate buffered saline, concentrated 10 times; contains Brij 0.5%.\\n\\nSAMP DIL 50x ： Proteic solution concentrated 50 times, with added phenol 0.05% and Bronidox 0.02%.\\n\\nSUBS TMB ：Tetramethylbenzidine 0.26 mg\/mL and hydrogen peroxide 0.01% stabilised in\\ncitrate buffer 0.05 mol\/L (pH 3.8).\\nH2SO4 0.3 M ：H2SO4 0.3 mol\/L.\\n\\n",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [],
    "licBaseId": "7283D528-62D4-47F1-BA19-8BCA61DF643E"
}